These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 15324384

  • 21. The proton-pump inhibitors: similarities and differences.
    Horn J.
    Clin Ther; 2000 Mar; 22(3):266-80; discussion 265. PubMed ID: 10963283
    [Abstract] [Full Text] [Related]

  • 22. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH.
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract] [Full Text] [Related]

  • 23. [Proton-pump inhibitor Rabeprazole: faster acid- and symptom-control].
    Dtsch Med Wochenschr; 1998 Nov 20; 123(47 Suppl):1-4. PubMed ID: 9856116
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative study of proton pump inhibitors].
    Herszényi L, Tulassay Z.
    Orv Hetil; 2001 Sep 09; 142(36):1953-61. PubMed ID: 11680100
    [Abstract] [Full Text] [Related]

  • 25. A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux.
    Tsugeno H, Mizuno M, Fujiki S, Okada H, Okamoto M, Hosaki Y, Ashida S, Mitsunobu F, Tanizaki Y, Shiratori Y.
    Scand J Gastroenterol; 2003 May 09; 38(5):456-61. PubMed ID: 12795453
    [Abstract] [Full Text] [Related]

  • 26. [Use of proton pump inhibitors in the treatment of gastroesophageal reflux disease].
    Maev IV, Balashova NN, Busarova GA.
    Klin Med (Mosk); 2003 May 09; 81(9):54-9. PubMed ID: 14598594
    [Abstract] [Full Text] [Related]

  • 27. [Oral cavity manifestations of gastroesophageal reflux disease].
    Maev IV, Barer GM, Busarova GA, Pustovoĭt EV, Polikanova EN, Burkov SG, Gurenev GL.
    Klin Med (Mosk); 2005 May 09; 83(11):33-8. PubMed ID: 16404937
    [Abstract] [Full Text] [Related]

  • 28. Clinical symptoms of FSSG in gastroesophageal reflux disease are critical for PPI treatment: Japanese multi-centers with 185 patients.
    Komatsu-Tanaka M, Iwakiri R, Fujimoto K, Fujiwara Y, Inamori M, Tanaka J, Shimatani T, Akiyama J, Ando T, Manabe N, Kinjo F, Deguchi R, Kusano M.
    Dig Endosc; 2012 Nov 09; 24(6):407-11. PubMed ID: 23078431
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Remák E, Brown RE, Yuen C, Robinson A.
    Curr Med Res Opin; 2005 Oct 09; 21(10):1505-17. PubMed ID: 16238890
    [Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.
    Kar P, Chandrashekar N, Devi S, Bhatia SJ, Alvares JF, Taneja A, Towar A.
    Indian J Gastroenterol; 2003 Oct 09; 22(4):153. PubMed ID: 12962446
    [No Abstract] [Full Text] [Related]

  • 31. Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.
    Thjodleifsson B.
    Expert Opin Pharmacother; 2004 Jan 09; 5(1):137-49. PubMed ID: 14680443
    [Abstract] [Full Text] [Related]

  • 32. Proton pump inhibitors: an update.
    Vanderhoff BT, Tahboub RM.
    Am Fam Physician; 2002 Jul 15; 66(2):273-80. PubMed ID: 12152963
    [Abstract] [Full Text] [Related]

  • 33. Rabeprazole controls GERD symptoms in a patient for whom treatment with lansoprazole failed: first report of "cluster GERD.".
    Oh DS, Ohning GV, Pisegna JR.
    Dig Dis Sci; 2005 May 15; 50(5):853-7. PubMed ID: 15912621
    [No Abstract] [Full Text] [Related]

  • 34. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
    Miner P, Orr W, Filippone J, Jokubaitis L, Sloan S.
    Am J Gastroenterol; 2002 Jun 15; 97(6):1332-9. PubMed ID: 12094846
    [Abstract] [Full Text] [Related]

  • 35. Monitoring cytochrome P-450 activity during rabeprazole treatment in patients with gastresophageal reflux disease.
    Giannini EG, Savarino V, Testa R.
    Dig Dis Sci; 2006 Sep 15; 51(9):1602-6. PubMed ID: 16927149
    [Abstract] [Full Text] [Related]

  • 36. An overview of proton pump inhibitors.
    Der G.
    Gastroenterol Nurs; 2003 Sep 15; 26(5):182-90. PubMed ID: 14603076
    [Abstract] [Full Text] [Related]

  • 37. Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
    Archimandritis AJ, Nikolopoulou V, Kouklakis G, Paraskevas E, Avgerinos A, Tsianos E, Triantafillidis JK, Hellenic Rabeprazole Study Group.
    Curr Med Res Opin; 2005 Apr 15; 21(4):603-10. PubMed ID: 15899110
    [Abstract] [Full Text] [Related]

  • 38. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
    Jeong HY, Lee BS, Sung JK, Lee TY, Yoon SJ, Kim SJ, Chung IK, Lee SH, Shin JE, Lee DS, Baek JT, Nam SW, Yoon SJ, Kim SH, Lee GS, Lee JM, Kim AN, Oh JI.
    Korean J Gastroenterol; 2006 Jan 15; 47(1):15-21. PubMed ID: 16434864
    [Abstract] [Full Text] [Related]

  • 39. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D.
    Aust Fam Physician; 1998 Jun 15; 27(6):487-91. PubMed ID: 9648315
    [Abstract] [Full Text] [Related]

  • 40. Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.
    DeVault KR.
    Aliment Pharmacol Ther; 2006 Mar 15; 23 Suppl 1():33-9. PubMed ID: 16483268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.